Sartorius shares in free fall: new lows despite positive market trends

Sartorius shares in free fall: new lows despite positive market trends

After Sartorius shares rose significantly on Thursday following the publication of the final quarterly figures, they slipped again on Friday. With a loss of 3.9 percent to 247.50 euros, it is currently the biggest loser in the DAX. The share has thus marked a new low since May 2020 and is down more than 20 percent since the forecast was lowered a week ago. The company's medium-term goals have also been under scrutiny since the forecast was lowered. Investors remain concerned and Sartorius plans to release related news early next year.

After the conference call on the weak third quarter, analyst Michael Heider from Warburg reduced his forecasts and cut his price target to 278 euros. However, he highlighted that management is confident that fundamental market trends are intact and double-digit growth should be possible in the medium term. CEO Joachim Kreuzburg emphasized that the recovery will slowly take hold over the next few quarters, but the company is confident that it can return to growth. The long-term outlook is positive thanks to an aging population and the growing importance of biopharmaceuticals.

With the recent price drop, Sartorius shares have slipped below the important support of the 52-week low of 291.90 euros and below the stop recommended by the SHAREHOLDER at 280.00 euros. Investors should wait for a clear trend reversal and regaining the 300 euro mark would brighten up the technical chart picture again.

According to a report by www.deraktionaer.de